Novocol Pharmaceutical of Canada Inc. (Novocol), and its affiliated owner, Septodont SAS of France, are world leaders in the production of dental anaesthetic cartridges. Novocol controls a large portion of the U.S. market, through its own brands, or the manufacture of other brands, and private label products.
Septodont Limited develops, manufactures, and distributes products for dental applications internationally. It offers endodontic products, such as auxiliary endodontic, desobturation products, endodontic equipment, intracanal medication, and obturation products. The company also provides endodontic restorative products, infection control products, pain control products, surgical products and preventive care products.
Septodont Limited is based in Maidstone, United Kingdom. The company has manufacturing plants in France, North America, and India.